GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment

Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Fredun Pharmaceuticals Ltd
Fredun Pharma sets July 16, 2026, as record date for 2:1 bonus share issue
BONUS ▲ Positive Development LOW RISK
📅 Filed on BSE: 10 Jul 2026, 05:01 PM IST  ·  BSE ID: ba8126d7-c20b-40d5-b42c-c286b7fe4fe9
View Original BSE Filing (PDF)
💡
In Simple Terms
Fredun Pharma is giving shareholders two free shares for every share they own, effective July 16, 2026.
🤖 AI Summary
  • Record date set for July 16, 2026, for 2:1 bonus equity share issue.
  • Shareholders receive two fully paid-up Equity Shares of ₹10 each for every one held.
  • Bonus share issuance approved by shareholders at the AGM held on June 30, 2026.
  • Deemed date of allotment for bonus shares is July 17, 2026 (T+1 from record date).
🔢 Key Numbers — exact figures from BSE filing, not rounded
Bonus Ratio
2:1
Face Value per Bonus Share
₹10/-
Record Date
16th July, 2026
Deemed Allotment Date
17th July, 2026
🏢 How This Affects the Company
💰
Financial Impact
The bonus issue does not directly impact the company's assets or reserves but increases the number of outstanding equity shares.
⚙️
Operational Impact
Operational adjustments will be made for warrant conversion ratios to maintain economic parity for warrant holders.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders as bonus shares will be credited directly to their demat accounts.
👤
Who Is Affected
All equity shareholders of record as of July 16, 2026, will be entitled to receive the bonus shares.
🔍
Management Signal
The bonus issue signals management's intent to reward shareholders and potentially increase the liquidity of the company's stock.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Confirmation of bonus share credit to demat accounts.
Company filings detailing post-bonus share capital structure.
Next quarterly results for any business impact reflection.
LOW RISK This is a standard corporate action with no inherent financial risk to the company.
💡 Investor Takeaway
Fredun Pharmaceuticals Ltd will issue 2 bonus equity shares of ₹10 each for every 1 held, with July 16, 2026, as the record date.
⚖️ Strengths & Concerns

✅ Positives

  • Bonus issue ratio of 2:1 offers shareholders increased equity stake in the company.
  • Bonus shares rank pari passu with existing equity shares, ensuring equal rights and benefits.
❓ Frequently Asked Questions
What is the record date for Fredun Pharmaceuticals Ltd's bonus share issue?
The record date for Fredun Pharmaceuticals Ltd's bonus share issue is July 16, 2026.
What is the bonus share ratio for Fredun Pharmaceuticals Ltd?
The bonus share ratio is 2:1, meaning shareholders will receive two fully paid-up Equity Shares of ₹10 each for every one existing share held.
When will the bonus shares be allotted?
The deemed date of allotment for the bonus equity shares is July 17, 2026, the next working day following the record date.
What is the face value of Fredun Pharmaceuticals Ltd's bonus shares?
The face value of the bonus equity shares to be issued is ₹10/- each.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.